Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 20

1.

Epigenetic control of group V phospholipase A2 expression in human malignant cells.

Menschikowski M, Hagelgans A, Nacke B, Jandeck C, Mareninova OA, Asatryan L, Siegert G.

Tumour Biol. 2015 Dec 29. [Epub ahead of print]

PMID:
26715269
2.

Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.

Menschikowski M, Hagelgans A, Nacke B, Jandeck C, Sukocheva O, Siegert G.

BMC Cancer. 2015 Dec 16;15:971. doi: 10.1186/s12885-015-1937-y.

3.

Silibinin down-regulates expression of secreted phospholipase A2 enzymes in cancer cells.

Hagelgans A, Nacke B, Zamaraeva M, Siegert G, Menschikowski M.

Anticancer Res. 2014 Apr;34(4):1723-9.

PMID:
24692702
4.

Serum amyloid A, phospholipase A₂-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases.

Menschikowski M, Hagelgans A, Fuessel S, Mareninova OA, Asatryan L, Wirth MP, Siegert G.

Inflamm Res. 2013 Dec;62(12):1063-72. doi: 10.1007/s00011-013-0665-5. Epub 2013 Sep 24.

PMID:
24061501
5.

Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.

Menschikowski M, Hagelgans A, Schuler U, Froeschke S, Rosner A, Siegert G.

Pathol Oncol Res. 2013 Oct;19(4):839-46. doi: 10.1007/s12253-013-9652-y. Epub 2013 Jun 1.

PMID:
23722320
6.

Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.

Hagelgans A, Menschikowski M, Fuessel S, Nacke B, Arneth BM, Wirth MP, Siegert G.

Exp Mol Pathol. 2013 Jun;94(3):458-65. doi: 10.1016/j.yexmp.2013.03.006. Epub 2013 Mar 27.

PMID:
23541763
7.

Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells.

Menschikowski M, Platzbecker U, Hagelgans A, Vogel M, Thiede C, Schönefeldt C, Lehnert R, Eisenhofer G, Siegert G.

BMC Cancer. 2012 Dec 5;12:576. doi: 10.1186/1471-2407-12-576.

8.

Regulation of thrombomodulin expression in prostate cancer cells.

Menschikowski M, Hagelgans A, Tiebel O, Vogel M, Eisenhofer G, Siegert G.

Cancer Lett. 2012 Sep 28;322(2):177-84. doi: 10.1016/j.canlet.2012.03.001. Epub 2012 Mar 7.

PMID:
22406829
9.

Serum levels of secreted group IIA phospholipase A(2) in benign prostatic hyperplasia and prostate cancer: a biomarker for inflammation or neoplasia?

Menschikowski M, Hagelgans A, Fuessel S, Mareninova OA, Neumeister V, Wirth MP, Siegert G.

Inflammation. 2012 Jun;35(3):1113-8. doi: 10.1007/s10753-011-9418-1.

PMID:
22189868
10.

Expression and shedding of endothelial protein C receptor in prostate cancer cells.

Menschikowski M, Hagelgans A, Tiebel O, Klinsmann L, Eisenhofer G, Siegert G.

Cancer Cell Int. 2011 Feb 15;11:4. doi: 10.1186/1475-2867-11-4.

11.

Reducing agents induce thrombomodulin shedding in human endothelial cells.

Menschikowski M, Hagelgans A, Eisenhofer G, Tiebel O, Siegert G.

Thromb Res. 2010 Aug;126(2):e88-93. doi: 10.1016/j.thromres.2010.05.006.

PMID:
20605193
12.

Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways.

Menschikowski M, Hagelgans A, Eisenhofer G, Siegert G.

Exp Cell Res. 2009 Sep 10;315(15):2673-82. doi: 10.1016/j.yexcr.2009.05.015. Epub 2009 May 23.

PMID:
19467228
13.

Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.

Menschikowski M, Hagelgans A, Kostka H, Eisenhofer G, Siegert G.

Neoplasia. 2008 Nov;10(11):1195-203.

14.
15.

On interaction of activated protein C with human aortic smooth muscle cells attenuating the secretory group IIA phospholipase A2 expression.

Menschikowski M, Hagelgans A, Hempel U, Lattke P, Ismailov I, Siegert G.

Thromb Res. 2008;122(1):69-76. Epub 2007 Oct 22.

PMID:
17936881
16.

Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?

Menschikowski M, Hagelgans A, Siegert G.

Prostaglandins Other Lipid Mediat. 2006 Mar;79(1-2):1-33. Epub 2005 Dec 27. Review.

PMID:
16516807
17.

Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells.

Menschikowski M, Hagelgans A, Heyne B, Hempel U, Neumeister V, Goez P, Jaross W, Siegert G.

Biochim Biophys Acta. 2005 Apr 15;1733(2-3):157-71. Epub 2005 Jan 22.

PMID:
15863363
18.
19.

Influence of plant terpenoids on the permeability of mitochondria and lipid bilayers.

Abramov AY, Zamaraeva MV, Hagelgans AI, Azimov RR, Krasilnikov OV.

Biochim Biophys Acta. 2001 May 2;1512(1):98-110.

20.

Ionophoretic properties of ferutinin.

Zamaraeva MV, Hagelgans AI, Abramov AY, Ternovsky VI, Merzlyak PG, Tashmukhamedov BA, Saidkhodzjaev AI.

Cell Calcium. 1997 Oct;22(4):235-41.

PMID:
9481474
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk